{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:37:08Z","timestamp":1762033028563,"version":"3.28.0"},"reference-count":36,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1011.040469","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T01:28:06Z","timestamp":1332725286000},"page":"1990-1995","source":"Crossref","is-referenced-by-count":13,"title":["Vaccines for Women Age 50 and Older1"],"prefix":"10.3201","volume":"10","author":[{"given":"Pierce","family":"Gardner","sequence":"first","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Pabbatireddy","sequence":"additional","affiliation":[{"name":"Stony Brook University, Stony Brook, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2004,11]]},"reference":[{"key":"key-10.3201\/eid1011.040469-201203250400-R1","first-page":"1","article-title":"Prevention and control of influenza.","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States.","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"key-10.3201\/eid1011.040469-201203250400-R3","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R4","first-page":"1","article-title":"Hepatitis B virus: a comprehension strategy for eliminating transmission in the United States through universal childhood vaccination; recommendations of the Immunization practices Advisory Committee (ACIP).","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0889-8561(02)00055-3","article-title":"Problems and solutions to the development of vaccines in the elderly.","volume":"23","author":"Effros","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"key-10.3201\/eid1011.040469-201203250400-R6","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0264-410X(99)00505-8","article-title":"Mucosal vaccination and immune responses in the elderly.","volume":"18","author":"Fujihashi","year":"2000","journal-title":"Vaccine"},{"key":"key-10.3201\/eid1011.040469-201203250400-R7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1600-065X.1997.tb01032.x","article-title":"Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development.","volume":"160","author":"LeMaoult","year":"1997","journal-title":"Immunol Rev"},{"key":"key-10.3201\/eid1011.040469-201203250400-R8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","article-title":"Immunogenicity of hepatitis B vaccines: implications for persons at occupational risk of hepatitis B virus infection.","volume":"15","author":"Averhoff","year":"1998","journal-title":"Am J Prev Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R9","doi-asserted-by":"publisher","first-page":"36s","DOI":"10.1016\/0002-9343(89)90530-5","article-title":"Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations.","volume":"87","author":"Hollinger","year":"1989","journal-title":"Am J Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJM199403313301312","article-title":"Herpes zoster with postherpetic neuralgia-persisting pain and frustration.","volume":"330","author":"Gilden","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/infdis\/166.2.253","article-title":"Immune response of elderly individuals to a live attenuated varicella vaccine.","volume":"166","author":"Levin","year":"1992","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1011.040469-201203250400-R12","first-page":"965","article-title":"Recommended adult immunization schedule\u2014United States, 2003\u20132004.","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R13","first-page":"561","article-title":"Assessing adult vaccination status at age 50 years","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/jama.1985.03350320060017","article-title":"Efficacy of influenza vaccine in nursing homes reduction in illness and complications during an influenza A (H3N2) epidemic.","volume":"253","author":"Patrarca","year":"1985","journal-title":"JAMA"},{"key":"key-10.3201\/eid1011.040469-201203250400-R15","unstructured":"Arden NH, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. Presented at Options for the Control of Influenza 1986;155\u201368."},{"key":"key-10.3201\/eid1011.040469-201203250400-R16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/aje\/154.2.155","article-title":"Influenza vaccine effectiveness among elderly nursing home residents: a cohort study.","volume":"154","author":"Monto","year":"2001","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid1011.040469-201203250400-R17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/175.1.1","article-title":"Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients.","volume":"175","author":"Potter","year":"1997","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1011.040469-201203250400-R19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0140-6736(99)05190-9","article-title":"Effects of influenza vaccination of health-care workers on mortality of elderly people in long term care: a randomised controlled trial.","volume":"355","author":"Carman","year":"2000","journal-title":"Lancet"},{"key":"key-10.3201\/eid1011.040469-201203250400-R20","first-page":"1","article-title":"Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/clinids\/11.4.586","article-title":"Community-acquired pneumonia requiring hospitalization: 5-year prospective study.","volume":"11","author":"Marrie","year":"1989","journal-title":"Rev Infect Dis"},{"key":"key-10.3201\/eid1011.040469-201203250400-R22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997.","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"key-10.3201\/eid1011.040469-201203250400-R23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults.","volume":"348","author":"Jackson","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0002-9343(97)00149-6","article-title":"Clinical efficacy of pneumococcal vaccine in the elderly a randomized, single-blind population-based trial.","volume":"103","author":"Koivula","year":"1997","journal-title":"Am J Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R25","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(00)04237-9","article-title":"Effects of a large-scale intervention with Influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study.","volume":"357","author":"Christenson","year":"2001","journal-title":"Lancet"},{"key":"key-10.3201\/eid1011.040469-201203250400-R26","first-page":"1019","article-title":"Influenza and pneumococcal vaccination levels among persons aged >65 years\u2014United States, 2001.","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jama.281.3.243","article-title":"Safety of revaccination with pneumococcal polysaccharide vaccine.","volume":"281","author":"Jackson","year":"1999","journal-title":"JAMA"},{"key":"key-10.3201\/eid1011.040469-201203250400-R28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.","volume":"342","author":"Nuorti","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R29","doi-asserted-by":"crossref","first-page":"960","DOI":"10.7326\/0003-4819-138-12-200306170-00007","article-title":"Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 65 years of age: role of comorbid conditions and race.","volume":"138","author":"Sisk","year":"2003","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R30","doi-asserted-by":"crossref","first-page":"999","DOI":"10.7326\/0003-4819-138-12-200306170-00014","article-title":"A need to update and revise the pneumococcal vaccine recommendations for adults.","volume":"138","author":"Gardner","year":"2003","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R31","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharider conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R32","first-page":"1","article-title":"Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures: recommendations of the Immunization Practices Advisory Committee (ACIP).","volume":"40","author":"Centers for Disease Control","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1011.040469-201203250400-R33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF02599616","article-title":"Should adult tetanus immunization be given as a\u00a0single vaccination at age 65? A cost-effectiveness analysis.","volume":"8","author":"Balestra","year":"1993","journal-title":"J Gen Intern Med"},{"key":"key-10.3201\/eid1011.040469-201203250400-R34","doi-asserted-by":"crossref","unstructured":"Gardner P. Issues related to the decennial tetanus-diphtheria toxoid booster recommendations in adults. In: Infectious disease clinics of North America. Vaccine recommendations: challenges and controversies. Volume 15. Philadelphia: WB Saunders; 2001. p. 143\u201353.","DOI":"10.1016\/S0891-5520(05)70272-5"},{"key":"key-10.3201\/eid1011.040469-201203250400-R35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"key-10.3201\/eid1011.040469-201203250400-R36","unstructured":"Centers for Disease Control and Prevention. Health information for international travel, 2003\u20132004. Yellow book. Atlanta: U.S. Department of Health and Human Services, Public Health Services; 2003."}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/10\/11\/04-0469_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:51:19Z","timestamp":1732589479000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/10\/11\/04-0469_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2004,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1011.040469","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}